Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Jul 27, 2021 12:28pm
79 Views
Post# 33610486

RE:RE:UP to 25% of Units Potentially Sold to Insiders

RE:RE:UP to 25% of Units Potentially Sold to Insiders

I don't agree with any of this. Usually when owners feel like they have a tiger by the tail, they don't dilute.

The insiders aren't going to take a big enough chunk out of this financing to not dilute themselves. With this financing they guarantee that the company has money to pay for expenses. As far as their shares are concerned, I would say they are aligned with shareholders if they bought $5M worth. Which they haven't, and won't. If they took down a massive chunk of the financing I'd say these guys believe in the business. But I haven't seen that yet.

Everyone here looks to have the mindset of an employee or a bureaucrat. They do not appear to be inventors, innovators, or mavericks of any kind. 


 

mercedesman wrote:

Accountprince wrote: This morning's disclosure is certainly an eye opener.  So undefined insiders could participate in up to 25% of the offering.  Something should have been filed 21 days prior to their participation in the closing (July 6 for that filing?).  I haven't seen anything yet.

The disclosure also lists some exemptions they are relying upon to exempt them from rules governing treatment of non-insider shareholders.  Anyone familiar with these rules?

So we were at $0.53 per share.  A bought deal for units is done at $.425 per share and the share price is engineered to less than $0.40 per share and stays there until closing.  Insider provision to acquire 25% of the issue disclosed in press release concurrent with the closing announcement.

So if insider participation should have been disclosed say July 6 does the FMV get established that day or do you wait until they "negotiate" the bought deal with the underwriters on July 20 when the price is dropped?  Many questions and no answers. 

Looks like insiders will do anything to acquire more shares.  That - in a very perverse way - validates the value we all feel is there.

 


I am not that familiar with the rules AP but I read the following paragraph...

"exemptions from the formal valuation and minority shareholder approval requirements provided under sections 5.5(a) and 5.7(a) of Multilateral Instrument 61-101 on the basis that participation in the Offering by insiders does not exceed 25% of the fair market value of the Company's market capitalization..."

...as meaning, that as long as insiders don't give themelves more than 25% of the MC they can push it through without minority shareholder approval, or the requirement of a more formal valuation.  A nice loophole for Cdn equities?

Perhaps the 25% requirement influences Toray or Birch Hill (definitionally insiders?) as to participation ?.

The required notice period is also an interresting question that I do not have the answer to.


Nevertheless, overall, your point about "validation" is well made.

My issue is not so much regarding validation as it is about making sure there is fairness.   

For several companies that I have owned...it almost seems as if sometimes there is an irresistable temptation by some insiders of Public companies I have owned, to use financings as an opportunity to gain an advantage over minofrity shareholders (MSr's).  They can do so in a varitey of ways including: (1) financing at too low a value (say in relation to potential, true value, recent highs, and Analyst targets), (2) granting unequal access to the finnancing to all shareholders, and (3) via the inclusion of various sweeteners suchs as options and warrants - that require no immediate cash outlay.   With an unequal ability to particpate - it can have the net effect of transferring a not insignificant share of  (always finite) future earnings & cash flows to savvy/privileged/fully in-the-know participants, often at the expense of some MS'rs that may have in fact  "brung them".  Some MSr's are painfully aware that the pie is finite, and shares/slices can effectively be redistributed over time.  There is no better opportunity to redistribute future earnings,than via financings and the annual option dole period. I often hear the excuse that MS'rs can participate by buying on the market , sometimes at or below the financing price.  Sure but that requires a not always available cash (vs say warrants), it needs to account for the true value of the sweeteners which may be off limits to MS'rs, and a certain amount of blind faith (not acting with all the facts).   Buying more shares adds risk and expends capital. Accepting options/warrants does not.

I like it when I am in charge of slicing up the pie at dessert time. Sometimes my hand slips and I accidentally end up with a bigger slice than some of my valued guests. My friends think I am sometimes crusty if I am handed a "too small" slice by someone else.

When dealing with two kids of course, the solution is to let one slice and the other one choose their peice (to keep the peace)...as  a matter of fairness.

MM







<< Previous
Bullboard Posts
Next >>